Abstract
Purpose :
Various dominant mutations in human GUCY2D (retinal guanylyl cyclase RetGC1) and GUCA1A (guanylyl cyclase activating protein GCAP1) trigger cone and rod degenerations by reducing sensitivity of RetGC1:GCAP1 complex to inhibition by Ca2+– thus elevating cGMP production and increasing Ca2+ influx via cGMP-gated channels in the dark. We explored a possibility that such degenerations can be suppressed by accelerating the decay of cGMP in the dark, achieved by a non-photoreceptor recombinant cGMP-specific phosphodiesterase (PDEr) introduced in photoreceptor outer segment.
Methods :
We engineered two types of recombinant non-photoreceptor PDE (PDEr) targeted to the outer segment using a prenylation signal at the C-terminus. The PDEr expressing mice (PDErTg) have been bred into two mouse models harboring R838S RetGC1 (a GUCY2D mutation causing autosomal dominant progressive cone-rod dystrophy) or Y99C GCAP1 (one of multiple GUCA1A mutations causing dominant cone- and cone-rod degenerations). The progression of retinal degeneration in the PDEr-expressing hybrids in comparison with the respective R838S RetGC1Tg and Y99C GCAP1Tg models was analyzed using optical coherence tomography (OCT) and histological sectioning. The retinal function was assessed using dark-adapted electroretinography (ERG).
Results :
One chimeric PDEr variant was expressed in mouse retinas under the control of rod opsin promoter. The non-photoreceptor PDEr harboring prenylation signal accumulated in PDErTg rod outer segments. Expression of PDEr strongly suppressed the reduction of the outer nuclear layer in PDErTg R838S RetGC1Tg and PDErTg Y99C GCAP1Tg retinas as compared to R838S RetGC1Tg and Y99C GCAP1Tg aged ~ 4 months and offset the loss of dark-adapted ERG.
Conclusions :
The results indicate that in mouse models expression of PDEr can counteract both GUCY2D- and GUCA1A-linked mutations that cause photoreceptor degenerations by elevating of cGMP production in the dark.
This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.